218 related articles for article (PubMed ID: 34121628)
1. A convergent synthetic platform for polymeric nanoparticle for the treatment of combination colorectal cancer therapy.
Zhang D; Jiang L; Liu C
J Biomater Sci Polym Ed; 2021 Oct; 32(14):1835-1848. PubMed ID: 34121628
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic Processing Approach to Controlling Drug Delivery Properties of Curcumin-Loaded Block Copolymer Nanoparticles.
Chen R; Wulff JE; Moffitt MG
Mol Pharm; 2018 Oct; 15(10):4517-4528. PubMed ID: 30179485
[TBL] [Abstract][Full Text] [Related]
3. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy.
Xiong K; Zhang Y; Wen Q; Luo J; Lu Y; Wu Z; Wang B; Chen Y; Zhao L; Fu S
Int J Pharm; 2020 Nov; 589():119875. PubMed ID: 32919003
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation.
Vakilinezhad MA; Amini A; Dara T; Alipour S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308
[TBL] [Abstract][Full Text] [Related]
7. Co-Delivery of Curcumin and Chrysin by Polymeric Nanoparticles Inhibit Synergistically Growth and hTERT Gene Expression in Human Colorectal Cancer Cells.
Lotfi-Attari J; Pilehvar-Soltanahmadi Y; Dadashpour M; Alipour S; Farajzadeh R; Javidfar S; Zarghami N
Nutr Cancer; 2017; 69(8):1290-1299. PubMed ID: 29083232
[TBL] [Abstract][Full Text] [Related]
8. Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.
Zhao X; Chen Q; Liu W; Li Y; Tang H; Liu X; Yang X
Int J Nanomedicine; 2015; 10():257-70. PubMed ID: 25565818
[TBL] [Abstract][Full Text] [Related]
9. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
10. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
[TBL] [Abstract][Full Text] [Related]
11. Efficient synergistic combination effect of Quercetin with Curcumin on breast cancer cell apoptosis through their loading into Apo ferritin cavity.
Mansourizadeh F; Alberti D; Bitonto V; Tripepi M; Sepehri H; Khoee S; Geninatti Crich S
Colloids Surf B Biointerfaces; 2020 Jul; 191():110982. PubMed ID: 32220813
[TBL] [Abstract][Full Text] [Related]
12. Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines.
Ebrahimi M; Babaei E; Neri F; Feizi MAH
Int J Pharm; 2021 May; 601():120592. PubMed ID: 33857585
[TBL] [Abstract][Full Text] [Related]
13. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
14. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharide-based nanoparticles fabricated from oppositely charged curdlan derivatives for curcumin encapsulation.
Yan JK; Wang ZW; Zhu J; Liu Y; Chen X; Li L
Int J Biol Macromol; 2022 Jul; 213():923-933. PubMed ID: 35654222
[TBL] [Abstract][Full Text] [Related]
17. Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells.
Firouzi Amandi A; Jokar E; Eslami M; Dadashpour M; Rezaie M; Yazdani Y; Nejati B
Med Oncol; 2023 May; 40(6):170. PubMed ID: 37156929
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
20. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
